This website is no longer actively maintained
Some material and features may be unavailable



U.S. and EU weigh in on Avandia, restricting its use

An EU agency has recommended a ban on the diabetes drug Avandia, while the U.S. FDA severely restricted its use.


  Need to Know, July 16, 2010

This week on Need to Know: Where art thou, Obama? A look at how Avandia and other possibly dangerous drugs make it to market. And a photojournalist travels to Bangladesh to document one of the world’s most dramatic health crises: childhood malnutrition.


  Timeline: The story of Avandia

A Need to Know chronology highlighting the history of the controversial diabetes drug Avandia, leading up to a big decision by the FDA on whether to pull it from the shelves.


Money and medicine: The story of Avandia

Dr. Jerome Kassirer, former editor-in-chief of the New England Journal of Medicine, discusses the state of the FDA today, and the conditions that make it possible for drugs like Avandia, which may be pulled from the market, to reach consumers.


Avandia on trial

Need to Know talks with Dr. Steven Nissen about the new reports linking the popular diabetes drug to an increased risk of heart failure.

      American Voices
      The Watch List
      climate desk